Companies / Theriva Biologics, Inc. / Activity
Activity — Theriva Biologics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $46.6K | +238K +112.30% | 450,263 0.98% of shares | low |
| Q4 2025 as of | Barclays PLC 13F manager | New | Common Stock | $6.9K | +33K | 32,569 0.07% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Add | Common Stock | $6.5K | +31K +38343.21% | 31,139 0.07% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Trim | Common Stock | $-5.3K | -27K -63.53% | 15,441 0.03% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | New | Common Stock | $683 | +495 | 495 <0.01% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Exit | Common Stock | $-683 | -495 -100.00% | 0 | low |
| Q3 2024 as of | Danske Bank A/S 13F manager | New | Common Stock | $1 | +1 | 1 <0.01% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common Stock | $0 | +1 | 1 <0.01% of shares | low |